Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease.

Hiroshi KataokaYosuke ShimadaSaori NishioShinya NakataniToshio MochizukiKen TsuchiyaJunichi HoshinoFumihiko HattandaHaruna KawanoKazushige HanaokaSumi HidakaDaisuke IchikawaEiji IshikawaKiyotaka UchiyamaHiroki HayashiShiho MakabeShun ManabeMichihiro MitobeAkinari SekineTatsuya SuwabeHirayasu KaiMahiro KurashigeKoichi SetaKeiji ShimazuTomofumi MoriyamaMai SatoTadashi OtsukaKan KatayamaWataru ShimabukuroTakuya FujimaruKenichiro MiuraKoichi NakanishiShigeo HorieKengo FuruichiHirokazu OkadaIchiei NaritaSatoru Muto

Published in: Clinical and experimental nephrology (2023)

The Japanese public intractable disease support system contributes to improvement of ADPKD treatment.

Keyphrases

polycystic kidney disease
healthcare
mental health
emergency department
adverse drug
replacement therapy
smoking cessation